I'm not saying there is no merit to having both Schwarber and JD on the 2022 roster.
Yes, we can create some complex chart whereby we can play Schwarber, JD, Dalbec, Verdugo, Renfroe, Kike and Arroyo 8-9 out of 10 games to accommodate keeping Schwarber at a cost that will surely cut into what we can spend on pitching, and I ask why do that?
Some things have changed since we added Schwarber at the deadline:
1) We went from having 4-5 SP'er we could basically count on to 1 or maybe 2, now that ERod stepped up.
2) We lose Richards, Perez, Ottavino and maybe ERod from this roster and have a winter spending budget that necessitates adding 2-4 pitchers.
3) We thought we needed a 1Bman, when we traded for Schwarber. We may not need one after what Dalbec showed us after July 30th.
4) We had doubts about Verdugo and JD on July 30th. Both were sub .700 for an extended period of time, when we traded for KS. Both look more solid, now and don't look like we need to hedge our bets on for 2022.
5) Kike and Renfroe only solidified their hold on FT roles for 2022, after the KS trade.
6) Only Arroyo remains a doubt for 2022, but almost everyone wants to keep Kike in CF, next year, even if it means bringing back Iggy or signing a 2Bman, this winter. So, Kike in CF means platooning Verdugo/Renfroe or squeezing them out of OF playing time, so Schwarber can get some games in there.
Sure, it's great to hedge our bets with a deepened bench, but I don't want any of these guys sitting on the bench, unless it's their regularly scheduled day off- maybe 5 games a year. The only exceptions might be Arroyo and Dalbec vs a few RHPs.
Of course, I'd rather have Scharbers bat in the line-up over Dalbec and or Arroyo, but taking away low cost capable players away from the line-up comes at a heavy financial cost. It's not just answering the question, "Is the gain worth it?"
The overriding question, IMO, is WHERE can we spend a limited winter spending budget to bring the most bang for the buck?
All our starting pitchers are healthy, and before yesterday, we were all agreeing we have but one SP'er we can trust. For the love of God!
I'm sorry for getting overly dramatic, but for the life of me, I'm thinking every penny, save maybe a couple for a utility IF'er like maybe Iggy, should and needs to be spent on pitching.
Just bringing back ERod will add $10M out of maybe $40M Bloom will have to spend- and that just keeps that one rotation slot even. Much is being said of expanding the roles and IP'd by Whitlock and Houck, and how that can fill much of our winter pitching needs, and I don't disagree, but let's face it, we are not adding 2 new pitchers with those two. At best, we are adding maybe 150 IP combined from 2021 to 2022. That's like adding one solid pitcher. If we keep them both in the pen, a possible scenario, we won't be adding much more than 50-100 IP from the two combined.
IMO, we need an ace or a very solid #2, and with Eovaldi's deal up after 2022, I'm leaning towards an ace. That's $25-30M right there. That's it- the whole budget:
$27M SP'er
+$10M ERod
$3M Iggy
We can't even replace Ottavino's innings.
How do we squeeze $15-18M a year for Schwarber into $40M and upgrade the staff like we need to?
Don't offer ERod a QO? Don't sign an ace? Move Houck and Whitlock to the rotation and pray that works, while filling 3-4 pen slots with the $18M left over after signing Schwarber and Iggy? Maybe.
I'd prefer to spend on pitching. I'd love to have Schwarber back, and if Henry okays us spending close to $55M, this winter, then count me in.